TY - JOUR
T1 - The K469E polymorphism of the ICAM-1 gene is a risk factor for peripheral arterial occlusive disease
AU - Gaetani, Eleonora
AU - Flex, Andrea
AU - Pola, Roberto
AU - Papaleo, Pierangelo
AU - De Martini, Demetrio
AU - Pola, Enrico
AU - Aloi, Francesco Saul
AU - Flore, Roberto Antonio
AU - Serricchio, Michele Lorenzo
AU - Gasbarrini, Antonio
AU - Pola, Paolo
PY - 2002
Y1 - 2002
N2 - Intercellular adhesion molecule-1 (ICAM-1) plays a crucial role in lymphocyte migration and activation, and is considered important in the pathogenesis of atherosclerosis. K469E is a common polymorphism of the ICAM-1 gene with potential functional significance. The aim of the present case-control study was to evaluate the association between this polymorphism and peripheral arterial occlusive disease (PAOD). ICAM-1 gene polymorphism was examined by polymerase chain reaction and restriction enzyme analysis in 75 Italian subjects affected by PAOD and 227 controls. The distribution of ICAM-1 genotypes in patients affected by PAOD was 32.1% EE, 50.6% EK, and 17.3% KK. The distribution of ICAM-1 genotypes in control subjects was 17.2% EE, 55.1% EK, and 27.7% KK. The EE genotype was significantly more common in patients than controls (P = 0.006). Logistic regression analysis indicated that the presence of the EE genotype significantly increases the risk of PAOD (odds ratio, 3.5; 95% confidence interval, 1.5-8.4; P = 0.004). This is the first study documenting a role of the ICAM-1 gene polymorphism in the pathogenesis of a cardiovascular disease, such as PAOD. Our data support the hypothesis that inflammatory mechanisms are important in the pathophysiology of vascular diseases with an atherosclerotic basis.
AB - Intercellular adhesion molecule-1 (ICAM-1) plays a crucial role in lymphocyte migration and activation, and is considered important in the pathogenesis of atherosclerosis. K469E is a common polymorphism of the ICAM-1 gene with potential functional significance. The aim of the present case-control study was to evaluate the association between this polymorphism and peripheral arterial occlusive disease (PAOD). ICAM-1 gene polymorphism was examined by polymerase chain reaction and restriction enzyme analysis in 75 Italian subjects affected by PAOD and 227 controls. The distribution of ICAM-1 genotypes in patients affected by PAOD was 32.1% EE, 50.6% EK, and 17.3% KK. The distribution of ICAM-1 genotypes in control subjects was 17.2% EE, 55.1% EK, and 27.7% KK. The EE genotype was significantly more common in patients than controls (P = 0.006). Logistic regression analysis indicated that the presence of the EE genotype significantly increases the risk of PAOD (odds ratio, 3.5; 95% confidence interval, 1.5-8.4; P = 0.004). This is the first study documenting a role of the ICAM-1 gene polymorphism in the pathogenesis of a cardiovascular disease, such as PAOD. Our data support the hypothesis that inflammatory mechanisms are important in the pathophysiology of vascular diseases with an atherosclerotic basis.
KW - ICAM-1
KW - atherosclerosis
KW - gene polymorphism
KW - peripheral arterial occlusive disease
KW - ICAM-1
KW - atherosclerosis
KW - gene polymorphism
KW - peripheral arterial occlusive disease
UR - http://hdl.handle.net/10807/20583
M3 - Article
SN - 0957-5235
SP - 483
EP - 488
JO - BLOOD COAGULATION & FIBRINOLYSIS
JF - BLOOD COAGULATION & FIBRINOLYSIS
ER -